Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2005

Open Access 01-12-2005 | Research article

The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase

Authors: Francesco Cappello, Sabrina David, Francesca Rappa, Fabio Bucchieri, Lorenzo Marasà, Tommaso E Bartolotta, Felicia Farina, Giovanni Zummo

Published in: BMC Cancer | Issue 1/2005

Login to get access

Abstract

Background

The involvement of Heat Shock Proteins (HSP) in cancer development and progression is a widely debated topic. The objective of the present study was to evaluate the presence and expression of HSP60 and HSP10 in a series of large bowel carcinomas and locoregional lymph nodes with and without metastases.

Methods

82 Astler and Coller's stage C2 colorectal cancers, of which 48 well-differentiated and 34 poorly-differentiated, were selected along with 661 lymph nodes, including 372 with metastases and 289 with reactive hyperplasia only, from the same tumours. Primitive tumours and both metastatic and reactive lymph nodes were studied; specifically, three different compartments of the lymph nodes, secondary follicle, paracortex and medullary sinus, were also analysed. An immunohistochemical research for HSP60 and HSP10 was performed and the semiquantitative results were analysed by statistical analysis to determine the correlation between HSPs expression and 1) tumour grading; 2) degree of inflammation; 3) number of lymph nodes involved; 4) lymph node compartment hyperplasia. Moreover, western blotting was performed on a smaller group of samples to confirm the immunohistochemical results.

Results

Our data show that the expression of HSP60, in both primary tumour and lymph node metastasis, is correlated with the tumoral grade, while the HSP10 expression is not. Nevertheless, the levels of HSP10 are commonly higher than the levels of HSP60. In addition, statistical analyses do not show any correlation between the degree of inflammation and the immunopositivity for both HSP60 and HSP10. Moreover, we find a significant correlation between the presence of lymph node metastases and the positivity for both HSP60 and HSP10. In particular, metastatic lymph nodes show a higher percentage of cells positive for both HSP60 and HSP10 in the secondary follicles, and for HSP10 in the medullary sinuses, when compared with hyperplastic lymph nodes.

Conclusion

HSP60 and HSP10 may have diagnostic and prognostic significance in the management of this tumour and their overexpression in tumoral cells may be functionally related to tumoral progression. We hypothesise that their expression in follicular and medullary cells of lymph nodes may be induced by formation of metastases. Further studies based on these observations could lead to a better understanding of the HSPs involvement in colorectal cancer progression, as well as other neoplasms.
Appendix
Available only for authorised users
Literature
1.
Wataba K, Saito T, Fukunaka K, Ashihara K, Nishimura M, Kudo R: Over-expression of heat shock proteins in carcinogenic endometrium. Int J Cancer. 2001, 91: 448-456. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1077>3.0.CO;2-F.CrossRefPubMed
2.
Rashmi R, Kumar S, Karunagaran D: Ectopic expression of HSP70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis. Carcinogenesis. 2004, 25: 179-187. 10.1093/carcin/bgh001.CrossRefPubMed
3.
Mosser DD, Morimoto RI: Molecular chaperones and the stress of oncogenesis. Oncogene. 2004, 23: 2907-2918. 10.1038/sj.onc.1207529.CrossRefPubMed
4.
Zhong L, Peng X, Hidalgo GE, Doherty DE, Stromberg AJ, Hirschowitz EA: Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients. Cancer Detect Prev. 2003, 27: 285-290. 10.1016/S0361-090X(03)00097-7.CrossRefPubMed
5.
O'Neill PA, Shaaban AM, West CR, Dodson A, Jarvis C, Moore P, Davies MP, Sibson DR, Foster CS: Increased risk of malignant progression in benign proliferating breast lesions defined by expression of heat shock protein 27. Br J Cancer. 2004, 90: 182-188. 10.1038/sj.bjc.6601449.CrossRefPubMedPubMedCentral
6.
Lambot MA, Peny MO, Fayt I, Haot J, Noel JC: Overexpression of 27-kDa heat shock protein relates to poor histological differentiation in human oesophageal squamous cell carcinoma. Histopathology. 2000, 36: 326-330. 10.1046/j.1365-2559.2000.00858.x.CrossRefPubMed
7.
Elpek GO, Karaveli S, Simsek T, Keles N, Aksoy NH: Expression of heat-shock proteins HSP27, HSP70 and HSP90 in malignant epithelial tumour of the ovaries. APMIS. 2003, 111: 523-530. 10.1034/j.1600-0463.2003.1110411.x.CrossRefPubMed
8.
Uozaki H, Ishida T, Kakiuchi C, Horiuchi H, Gotoh T, Iijima T, Imamura T, Machinami R: Expression of heat shock proteins in osteosarcoma and its relationship to prognosis. Pathol Res Pract. 2000, 196: 665-673.CrossRefPubMed
9.
Lauten M, Beger C, Gerdes K, Asgedom G, Kardinal C, Welte K, Schrappe M: Expression of heat-shock protein 90 in glucocorticoid-sensitive and -resistant childhood acute lymphoblastic leukaemia. Leukemia. 2003, 17: 1551-1556. 10.1038/sj.leu.2403027.CrossRefPubMed
10.
Ciocca DR, Clark GM, Tandon AK, Fuqua SA, Welch WJ, McGuire WL: Heat shock protein HSP70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst. 1993, 85: 570-574.CrossRefPubMed
11.
Storm FK, Mahvi DM, Gilchrist KW: Heat shock protein 27 overexpression in breast cancer lymph node metastasis. Ann Surg Oncol. 1996, 3: 570-573.CrossRefPubMed
12.
Noguchi T, Takeno S, Shibata T, Uchida Y, Yokoyama S, Muller W: Expression of heat shock protein 70 in grossly resected esophageal squamous cell carcinoma. Ann Thorac Surg. 2002, 74: 222-226. 10.1016/S0003-4975(02)03641-X.CrossRefPubMed
13.
Hwang TS, Han HS, Choi HK, Lee YJ, Kim YJ, Han MY, Park YM: Differential, stage-dependent expression of HSP70, HSP110 and Bcl-2 in colorectal cancer. J Gastroenterol Hepatol. 2003, 18: 690-700. 10.1046/j.1440-1746.2003.03011.x.CrossRefPubMed
14.
Noguchi T, Wada S, Takeno S, Moriyama H, Kimura Y, Uchida Y: Lymph node metastasis could be predicted by evaluation of macrophage infiltration and HSP70 expression in superficial carcinoma of the esophagus. Oncol Rep. 2003, 10: 1161-1164.PubMed
15.
Zuo DS, Dai J, Bo AH, Fan J, Xiao XY: Significance of expression of heat shock protein90alpha in human gastric cancer. World J Gastroenterol. 2003, 9: 2616-2618.PubMedPubMedCentral
16.
Richardson A, Schwager F, Landry SJ, Georgopoulos C: The importance of a mobile loop in regulating chaperonin/ co-chaperonin interaction: humans versus Escherichia coli. J Biol Chem. 2001, 276: 4981-4987. 10.1074/jbc.M008628200.CrossRefPubMed
17.
Cappello F, Bellafiore M, Palma A, Marciano V, Martorana G, Belfiore P, Martorana A, Farina F, Zummo G, Bucchieri F: Expression of 60-kD heat shock protein increases during carcinogenesis in the uterine exocervix. Pathobiology. 2002, 70: 83-88. 10.1159/000067304.CrossRefPubMed
18.
Cappello F, Bellafiore M, David S, Anzalone R, Zummo G: Ten kilodalton heat shock protein (HSP10) is overexpressed during carcinogenesis of large bowel and uterine exocervix. Cancer Lett. 2003, 196: 35-41. 10.1016/S0304-3835(03)00212-X.CrossRefPubMed
19.
Cappello F, Bellafiore M, Palma A, David S, Marciano V, Bartolotta T, Sciume C, Modica G, Farina F, Zummo G, Bucchieri F: 60KDa chaperonin (HSP60) is over-expressed during colorectal carcinogenesis. Eur J Histochem. 2003, 47: 105-110.CrossRefPubMed
20.
Cappello F, Rappa F, David S, Anzalone R, Zummo G: Immunohistochemical evaluation of PCNA, p53, HSP60, HSP10 and MUC-2 presence and expression in prostate carcinogenesis. Anticancer Res. 2003, 23: 1325-1331.PubMed
21.
Cappello F: HSP60 and HSP10 as diagnostic and prognostic tools in the management of exocervical carcinoma. Gynecol Oncol. 2003, 91: 661-10.1016/j.ygyno.2003.08.009.CrossRefPubMed
22.
Pomara G, Cappello F: RE: Heat shock proteins: their role in urological tumors. J Urol. 2003, 170: 927-928. 10.1097/01.ju.0000080564.23671.32.CrossRefPubMed
23.
Hsu PL, Hsu SM: Abundance of heat shock proteins (HSP89, HSP60, and HSP27) in malignant cells of Hodgkin's disease. Cancer Res. 1998, 58: 5507-5513.PubMed
24.
Schneider J, Jimenez E, Marenbach K, Romero H, Marx D, Meden H: Immunohistochemical detection of HSP60-expression in human ovarian cancer. Correlation with survival in a series of 247 patients. Anticancer Res. 1999, 19: 2141-2146.PubMed
25.
Laad AD, Thomas ML, Fakih AR, Chiplunkar SV: Human gamma delta T cells recognize heat shock protein-60 on oral tumor cells. Int J Cancer. 1999, 80: 709-714. 10.1002/(SICI)1097-0215(19990301)80:5<709::AID-IJC14>3.0.CO;2-R.CrossRefPubMed
26.
Trieb K, Gerth R, Windhager R, Grohs JG, Holzer G, Berger P, Kotz R: Serum antibodies against the heat shock protein 60 are elevated in patients with osteosarcoma. Immunobiology. 2000, 201: 368-376.CrossRefPubMed
27.
Lebret T, Watson RW, Molinie V, O'Neill A, Gabriel C, Fitzpatrick JM, Botto H: Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma. Cancer. 2003, 98: 970-977. 10.1002/cncr.11594.CrossRefPubMed
28.
Pignatelli D, Ferreira J, Soares P, Costa MJ, Magalhaes MC: Immunohistochemical study of heat shock proteins 27, 60 and 70 in the normal human adrenal and in adrenal tumors with suppressed ACTH production. Microsc Res Tech. 2003, 61: 315-323. 10.1002/jemt.10341.CrossRefPubMed
29.
Cappello F, Tripodo C, Farina F, Franco V, Zummo G: HSP10 selective preference for myeloid and megakaryocytic precursors in normal human bone marrow. Eur J Histochem. 2004, 49: 261-265.
30.
Papp E, Nardai G, Soti C, Csermely P: Molecular chaperones, stress proteins and redox homeostasis. Biofactors. 2003, 17: 249-257.CrossRefPubMed
31.
Isomoto H, Oka M, Yano Y, Kanazawa Y, Soda H, Terada R, Yasutake T, Nakayama T, Shikuwa S, Takeshima F, Udono H, Murata I, Ohtsuka K, Kohno S: Expression of heat shock protein (HSP) 70 and HSP 40 in gastric cancer. Cancer Lett. 2003, 198: 219-228. 10.1016/S0304-3835(03)00305-7.CrossRefPubMed
32.
Sagol O, Tuna B, Coker A, Karademir S, Obuz F, Astarcioglu H, Kupelioglu A, Astarcioglu I, Topalak O: Immunohistochemical detection of pS2 protein and heat shock protein-70 in pancreatic adenocarcinomas. Relationship with disease extent and patient survival. Pathol Res Pract. 2002, 198: 77-84. 10.1078/0344-0338-00190.CrossRefPubMed
33.
Kawanishi K, Shiozaki H, Doki Y, Sakita I, Inoue M, Yano M, Tsujinaka T, Shamma A, Monden M: Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus. Cancer. 1999, 85: 1649-1657. 10.1002/(SICI)1097-0142(19990415)85:8<1649::AID-CNCR2>3.0.CO;2-V.CrossRefPubMed
34.
Tetu B, Brisson J, Landry J, Huot J: Prognostic significance of heat-shock protein-27 in node-positive breast carcinoma: an immunohistochemical study. Breast Cancer Res Treat. 1995, 36: 93-97. 10.1007/BF00690189.CrossRefPubMed
35.
Piselli P, Vendetti S, Vismara D, Cicconi R, Poccia F, Colizzi V, Delpino A: Different expression of CD44, ICAM-1, and HSP60 on primary tumor and metastases of a human pancreatic carcinoma growing in scid mice. Anticancer Res. 2000, 20: 825-831.PubMed
36.
Schneider J, Pollan M, Ruibal A, Jimenez E, Lucas AR, Nunez MI, Sanchez J, Tejerina A: Histologic grade and CD44 are independent predictors of axillary lymph node invasion in early (T1) breast cancer. Tumour Biol. 1999, 20: 319-30. 10.1159/000030096.CrossRefPubMed
37.
Ito T, Kawabe R, Kurasono Y, Hara M, Kitamura H, Fujita K, Kanisawa M: Expression of heat shock proteins in squamous cell carcinoma of the tongue: an immunohistochemical study. J Oral Pathol Med. 1998, 27: 18-22.CrossRefPubMed
38.
Samali A, Cai J, Zhivotovsky B, Jones DP, Orrenius S: Presence of a pre-apoptotic complex of pro-caspase-3, HSP60 and HSP10 in the mitochondrial fraction of jurkat cells. EMBO J. 1999, 18: 2040-2048. 10.1093/emboj/18.8.2040.CrossRefPubMedPubMedCentral
39.
Xanthoudakis S, Roy S, Rasper D, Hennessey T, Aubin Y, Cassady R, Tawa P, Ruel R, Rosen A, Nicholson DW: HSP60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis. EMBO J. 1999, 18: 2049-2056. 10.1093/emboj/18.8.2049.CrossRefPubMedPubMedCentral
40.
Lin KM, Lin B, Lian IY, Mestril R, Scheffler IE, Dillmann WH: Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation. 2001, 103: 1787-1792.CrossRefPubMed
41.
Lin KM, Hollander JM, Kao VY, Lin B, Macpherson L, Dillmann WH: Myocyte protection by 10 kD heat shock protein (HSP10) involves the mobile loop and attenuation of the Ras GTP-ase pathway. FASEB J. 2004, 18: 1004-1006.PubMed
42.
Yang EC, Guo J, Diehl G, DeSouza L, Rodrigues MJ, Romaschin AD, Colgan TJ, Siu KW: Protein expression profiling of endometrial malignancies reveals a new tumor marker: chaperonin 10. J Proteome Res. 2004, 3: 636-643. 10.1021/pr049975z.CrossRefPubMed
43.
Hsu SM, Cossman J, Jaffe ES: Lymphocyte subsets in normal human lymphoid tissues. Am J Clin Pathol. 1983, 80: 21-30.CrossRefPubMed
44.
Dardick I, Dardick AM: Morphometry of normal human lymphoid tissues. Nuclear parameters for comparative studies of lymphoma. Arch Pathol Lab Med. 1984, 108: 190-196.PubMed
45.
van den Oord JJ, de Wolf-Peeters C, Desmet VJ: The composite nodule. A structural and functional unit of the reactive human lymph node. Am J Pathol. 1986, 122: 83-91.PubMedPubMedCentral
46.
Cappello F, Bellafiore M, Palma A, Marciano V, Zummo G, Farina F, Bucchieri F: Study of axillary lymph node asymmetry in a female population. J Anat. 2001, 199: 617-620. 10.1017/S002187820100841X.CrossRefPubMedPubMedCentral
47.
Cappello F, Barresi E, Martorana A: Breast cancer and lymph node metastasis: relation of lymph node dimensions and metastasis. Pathologica. 2000, 92: 5-8.PubMed
48.
Gonzalez Bosquet J, Keeney GL, Mariani A, Webb MJ, Cliby WA: Cytokeratin staining of resected lymph nodes may improve the sensitivity of surgical staging for endometrial cancer. Gynecol Oncol. 2003, 91: 518-525. 10.1016/j.ygyno.2003.08.026.CrossRefPubMed
49.
Jiao X, Eslami A, Ioffe O, Kwong KF, Henry M, Zeng Q, Refaely Y, Burrows W, Gamliel Z, Krasna MJ: Immunohistochemistry analysis of micrometastasis in pretreatment lymph nodes from patients with esophageal cancer. Ann Thorac Surg. 2003, 76: 996-999. 10.1016/S0003-4975(03)00658-1.CrossRefPubMed
50.
Lara JF, Young SM, Velilla RE, Santoro EJ, Templeton SF: The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up. Cancer. 2003, 98: 2105-2113. 10.1002/cncr.11761.CrossRefPubMed
51.
Munakata S, Aihara T, Morino H, Takatsuka Y: Application of immunofluorescence for intraoperative evaluation of sentinel lymph nodes in patients with breast carcinoma. Cancer. 2003, 98: 1562-1568. 10.1002/cncr.11689.CrossRefPubMed
52.
Juretzka MM, Jensen KC, Longacre TA, Teng NN, Husain A: Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis. Gynecol Oncol. 2004, 93: 107-111. 10.1016/j.ygyno.2003.11.033.CrossRefPubMed
53.
Lentz SE, Muderspach LI, Felix JC, Ye W, Groshen S, Amezcua CA: Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients. Obstet Gynecol. 2004, 103: 1204-1210.CrossRefPubMed
54.
Meinhardt A, Wilhelm B, Seitz J: Expression of mitochondrial marker proteins during spermatogenesis. Hum Reprod Update. 1999, 5: 108-119. 10.1093/humupd/5.2.108.CrossRefPubMed
55.
Bethke K, Staib F, Distler M, Schmitt U, Jonuleit H, Enk AH, Galle PR, Heike M: Different efficiency of heat shock proteins (HSP) to activate human monocytes and dendritic cells: superiority of HSP60. J Immunol. 2002, 169: 6141-6148.CrossRefPubMed
56.
Flohe SB, Bruggemann J, Lendemans S, Nikulina M, Meierhoff G, Flohe S, Kolb H: Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J Immunol. 2003, 170: 2340-2348.CrossRefPubMed
57.
Dubaquie Y, Looser R, Funfschilling U, Jeno P, Rospert S: Identification of in vivo substrates of the yeast mitochondrial chaperonins reveals overlapping but non-identical requirement for HSP60 and HSP10. EMBO J. 1998, 17: 5868-5876. 10.1093/emboj/17.20.5868.CrossRefPubMedPubMedCentral
58.
Cuezva JM, Chen G, Alonso AM, Isidoro A, Misek DE, Hanash SM, Beer DG: The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis. 2004, 25: 1157-1163. 10.1093/carcin/bgh113.CrossRefPubMed
59.
Leopardi O, Naughten W, Giannulis I, Mirra M, Frigo B: HSP70 is selectively over-expressed in the blast cells of the germinal centres and paracortex in reactive lymph nodes. Histopathology. 2001, 39: 566-571. 10.1046/j.1365-2559.2001.01293.x.CrossRefPubMed
60.
Breloer M, More SH, Osterloh A, Stelter F, Jack RS, Bonin A: Macrophages as main inducers of IFN-gamma in T cells following administration of human and mouse heat shock protein 60. Int Immunol. 2002, 14: 1247-1253. 10.1093/intimm/dxf090.CrossRefPubMed
Metadata
Title
The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase
Authors
Francesco Cappello
Sabrina David
Francesca Rappa
Fabio Bucchieri
Lorenzo Marasà
Tommaso E Bartolotta
Felicia Farina
Giovanni Zummo
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2005
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-5-139

Other articles of this Issue 1/2005

BMC Cancer 1/2005 Go to the issue

Research article

Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis

Research article

Short- and long-term cause-specific survival of patients with inflammatory breast cancer

Research article

Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics

Research article

Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma

Research article

Neogenin expression may be inversely correlated to the tumorigenicity of human breast cancer

Research article

Survivin expression and its clinical significance in pancreatic cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits